Carta científica
Anafilaxia tras la administración de rocuronio. Potencial uso off-label de sugammadex
Rocuronium-induced anaphylaxis. Potential off-label use of sugammadex
J.A. Silva-Obregón
, D. Gamero-Donis, J.E. Romo-Gonzales, C. Benito-Puncel, J.M. Borrallo-Pérez, C. Marian-Crespo
Corresponding author
Servicio de Medicina Intensiva, Hospital Universitario de Guadalajara, Guadalajara, España
Read
16405
Timeswas read the article
4846
Total PDF
11559
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 8 | 13 |
| 2025 5 | 158 | 70 | 228 |
| 2025 4 | 149 | 49 | 198 |
| 2025 3 | 178 | 58 | 236 |
| 2025 2 | 159 | 49 | 208 |
| 2025 1 | 176 | 61 | 237 |
| 2024 12 | 177 | 70 | 247 |
| 2024 11 | 159 | 96 | 255 |
| 2024 10 | 167 | 99 | 266 |
| 2024 9 | 176 | 67 | 243 |
| 2024 8 | 172 | 61 | 233 |
| 2024 7 | 144 | 49 | 193 |
| 2024 6 | 164 | 96 | 260 |
| 2024 5 | 147 | 70 | 217 |
| 2024 4 | 124 | 64 | 188 |
| 2024 3 | 124 | 53 | 177 |
| 2024 2 | 127 | 52 | 179 |
| 2024 1 | 138 | 40 | 178 |
| 2023 12 | 90 | 48 | 138 |
| 2023 11 | 111 | 67 | 178 |
| 2023 10 | 130 | 50 | 180 |
| 2023 9 | 101 | 45 | 146 |
| 2023 8 | 123 | 26 | 149 |
| 2023 7 | 143 | 35 | 178 |
| 2023 6 | 132 | 25 | 157 |
| 2023 5 | 144 | 48 | 192 |
| 2023 4 | 121 | 51 | 172 |
| 2023 3 | 526 | 65 | 591 |
| 2023 2 | 140 | 65 | 205 |
| 2023 1 | 140 | 44 | 184 |
| 2022 12 | 114 | 57 | 171 |
| 2022 11 | 147 | 61 | 208 |
| 2022 10 | 154 | 72 | 226 |
| 2022 9 | 128 | 63 | 191 |
| 2022 8 | 94 | 60 | 154 |
| 2022 7 | 83 | 77 | 160 |
| 2022 6 | 112 | 48 | 160 |
| 2022 5 | 79 | 73 | 152 |
| 2022 4 | 86 | 65 | 151 |
| 2022 3 | 125 | 84 | 209 |
| 2022 2 | 80 | 56 | 136 |
| 2022 1 | 102 | 84 | 186 |
| 2021 12 | 82 | 56 | 138 |
| 2021 11 | 104 | 83 | 187 |
| 2021 10 | 159 | 101 | 260 |
| 2021 9 | 96 | 75 | 171 |
| 2021 8 | 88 | 62 | 150 |
| 2021 7 | 90 | 63 | 153 |
| 2021 6 | 77 | 47 | 124 |
| 2021 5 | 103 | 62 | 165 |
| 2021 4 | 246 | 113 | 359 |
| 2021 3 | 142 | 49 | 191 |
| 2021 2 | 158 | 40 | 198 |
| 2021 1 | 103 | 37 | 140 |
| 2020 12 | 89 | 36 | 125 |
| 2020 11 | 86 | 25 | 111 |
| 2020 10 | 94 | 44 | 138 |
| 2020 9 | 101 | 41 | 142 |
| 2020 8 | 91 | 43 | 134 |
| 2020 7 | 81 | 36 | 117 |
| 2020 6 | 78 | 28 | 106 |
| 2020 5 | 104 | 41 | 145 |
| 2020 4 | 63 | 38 | 101 |
| 2020 3 | 73 | 27 | 100 |
| 2020 2 | 183 | 38 | 221 |
| 2020 1 | 73 | 38 | 111 |
| 2019 12 | 81 | 47 | 128 |
| 2019 11 | 97 | 31 | 128 |
| 2019 10 | 98 | 47 | 145 |
| 2019 9 | 88 | 37 | 125 |
| 2019 8 | 85 | 44 | 129 |
| 2019 7 | 71 | 31 | 102 |
| 2019 6 | 88 | 33 | 121 |
| 2019 5 | 127 | 69 | 196 |
| 2019 4 | 96 | 51 | 147 |
| 2019 3 | 84 | 57 | 141 |
| 2019 2 | 81 | 41 | 122 |
| 2019 1 | 77 | 59 | 136 |
| 2018 12 | 108 | 52 | 160 |
| 2018 11 | 194 | 79 | 273 |
| 2018 10 | 147 | 41 | 188 |
| 2018 9 | 78 | 20 | 98 |
| 2018 8 | 94 | 14 | 108 |
| 2018 7 | 64 | 21 | 85 |
| 2018 6 | 59 | 15 | 74 |
| 2018 5 | 25 | 16 | 41 |
| 2018 4 | 63 | 19 | 82 |
| 2018 3 | 63 | 13 | 76 |
| 2018 2 | 31 | 16 | 47 |
| 2018 1 | 54 | 27 | 81 |
| 2017 12 | 40 | 13 | 53 |
| 2017 11 | 36 | 17 | 53 |
| 2017 10 | 63 | 10 | 73 |
| 2017 9 | 31 | 26 | 57 |
| 2017 8 | 37 | 18 | 55 |
| 2017 7 | 48 | 24 | 72 |
| 2017 6 | 45 | 10 | 55 |
| 2017 5 | 49 | 9 | 58 |
| 2017 4 | 42 | 2 | 44 |
| 2017 3 | 46 | 38 | 84 |
| 2017 2 | 131 | 6 | 137 |
| 2017 1 | 35 | 5 | 40 |
| 2016 12 | 69 | 10 | 79 |
| 2016 11 | 76 | 11 | 87 |
| 2016 10 | 98 | 24 | 122 |
| 2016 9 | 104 | 14 | 118 |
| 2016 8 | 75 | 14 | 89 |
| 2016 7 | 48 | 11 | 59 |
| 2015 12 | 2 | 0 | 2 |
| 2015 1 | 1 | 0 | 1 |
| 2014 11 | 1 | 0 | 1 |
| 2014 8 | 1 | 0 | 1 |
| 2014 6 | 2 | 0 | 2 |
| 2014 3 | 3 | 0 | 3 |
| 2014 2 | 7 | 0 | 7 |
| 2014 1 | 3 | 0 | 3 |
Show all
